TRANSFUSION
Any adverse reaction to the transfusion of blood or blood components should be reported
to Blood Bank personnel as soon as possible.
The Blood Bank is required to report any death resulting from transfusion to the Food
and Drug Administration.
Reactions may be separated into reactions that present in proximity to the transfusion and
those that present at some time subsequent to the transfusion. Suspected post-transfusion
disease, which may present at a considerable time following transfusion, must also be
reported to the Blood Bank. Investigation of these reports may result in identification of
"carrier" donors who are removed from the donor pool
A Blood Bank physician should be consulted regarding the evaluation of patients with
reactions, as well as selection of appropriate blood components for future transfusion.
In the case of a mild urticarial and febrile reactions, with no other signs or symptoms
attributable to blood transfusion, it may be possible to reinitiate the blood transfusion
Such a decision must be arrived at through consultation between the physician reporting
the reaction and a Blood Bank physician
It is suggested that patients receiving granulocytes who have a history of febrile reactions
to blood components be pretreated with antipyretic agents if there are no
contraindications to the use of these drugs. See Febrile Transfusion Reactions. In general,
transfusion of Granulocytes should be terminated only for such complications as severe
flank pain, chest pain, hemoglobinemia and hemoglobinuria, hypotension, laryngospasm,
or acute pulmonary injury.
Reaction Type Symptoms Cause Frequency Prevention
Allergic - urticaria allergic reactions may be associated this reaction is caused by foreign1% of recipients
with laryngeal edema and plasma proteins
bronchospasm.
Reactions manifest cardiovascular
instability that includes
hypotension, tachycardia, loss of
consciousness, cardiac arrhythmia,
shock and cardiac arrest.
TRALI abrupt onset of noncardiogenic TRALI has been associated withTRALI is a rare Most cases of TRALI
pulmonary edema Severe cases the presence of antibodies in the though under resolve within 72 hours
may require assisted ventilation donor plasma reactive torecognized although fatalities may
with high FIO2.. recipient leukocyte antigens orcomplication of occur in approximately 10
with the production oftransfusion percent of cases.
inflammatory mediators during
storage of cellular blood
components
Bacterial hypotension, shock, fever and Bacterial contamination occursrare but difficult
Contamination chills, nausea and vomiting, and when a small number of bacteriato detect prior to
respiratory distress. Diagnosis is enter a blood component duringtransfusion
established by Gram stain and collection or processing.. DuringAutologous
blood culture of both the blood storage, bacteria may proliferate,blood may be
component and the resulting in a large number of contaminated
recipient.distress organisms, and possiblewith bacteria,
endotoxin, being given with theparticularly if
transfusion the patient had
an active
infection at the
time of
donation.
Hypotension A drop of at least 10 mm Hg in Some reactions have been
systolic or diastolic arterial blood associated with angiotensin
pressure in the absence of signs or converting enzyme (ACE)
symptoms of other transfusion inhibitor drugs or the use of
reactions leukocyte reduction filters.
if the immediate pretransfusion Hypotensive reactions have been
blood pressure is elevated from the associated with red cell and
patient�s typical blood pressure, platelet transfusions.
and the arterial pressure does not
fall below the patient�s usual
blood pressure, it should not be
considered a hypotensive reaction.
The onset of hypotension is during
the transfusion, and resolves
quickly with discontinuation of the
transfusion.
If hypotension persists beyond 30
minutes after discontinuing the
transfusion, another diagnosis
should be strongly considered.
Graft-vs-Host Disease rash, fever, diarrhea, cytopenia and viable T lymphocytes in bloodRare Irradiation of cellular
GVHD liver dysfunction 3-4 weeks after components are transfused, components
transfusion engraft and react against the
recipient's tissues and the The Blood Bank must be
recipient is unable to reject the apprised of the immune
donor lymphocytes because of status, or diagnosis, of the
immunodeficiency, severe patient so that cellular
immunosuppression, or shared components intended for
HLA antigens transfusion of
immunocompromised
associated with bone marrow patients and blood
transplantation. Transfusion components from directed
associated GVHD occurs. It (designated) donors will
typically. Transfusion associated be irradiated. Irradiation of
GVHD carries a very poor blood red cell containing
prognosis. components decreases the
red cell survival and
increases the potassium of
the component. There is
no apparent effect on
platelet survival. Fresh
Frozen Plasma (FFP) and
cryoprecipitated AHG
(CRYO) need not be
irradiated because these
components do not contain
enough viable
lymphocytes to cause
GVHD.
Non-immune hemoglobinemia and Lysis of red cells can occur due Rare
Hemolysis hemoglobinuria Transient to improper storage, handling, or
hemodynamic, pulmonary and transfusion conditions.
renal impairment may occur.
cardiac arrhythmia due to mishandling or storage of blood
yyperkalemia may occur, components
particularly in patients with renal
failure. the contents of the blood bags are
available for study. The blood
bag together with attached tubing
and intravenous fluids should be
saved for further investigations.
Post-transfusion thrombocytopenia that is frequently the patient makes an alloantibodyRare Platelet transfusion is of
purpura (PTP) profound, purpura, or bleeding in response to platelet antigens in very little value in PTP;
the transfused blood that for a however, therapeutic
Febrile reactions have been period of time causes destruction plasma exchange may be
reported retrospectively with the of autologous antigen negative beneficial Since
implicated transfusion platelets autologous platelets do not
survive in circulation,
thrombocytopenia typically 7-48 there is no expectation that
days after transfusion transfused platelets
regardless of antigen
matching will do any
PTP must be differentiated from the better.
far more common
alloimmunization to platelet
antigens. Consultation with a Blood Reserved platelet
Bank physician is recommended in transfusion for patients
evaluating such patients. with active bleeding.